Quinnova Pharmaceuticals, LLC — Delivering Innovation
A wholly owned subsidiary of AmDerma, LLC, Quinnova Pharmaceuticals, LLC, is a specialty pharmaceutical company founded on innovative, patent-protected dermal delivery technologies. Our drug delivery platforms are utilized to transport safe and effective pharmaceutical ingredients, through the epidermis, in unique, convenient, and cosmetically elegant formulations. Addressing a wide variety of skin conditions, it is our mission to provide superior treatment solutions and product value to clinicians and patients alike.
Quinnova Pharmaceuticals, LLC aspires to become the premier provider of therapeutic skin and wound products in the United States by employing focused research, product development, and professional and ethical sales and marketing. By maintaining an environment that fosters trust and loyalty while rewarding achievement and success, we will build increased value for our customers, healthcare providers, and business partners. For more about Quinnova link to "Management Team" page.
Quinnova currently utilizes three independent proprietary technology platforms to address a wide variety of skin and wound disorders. Our ProDerm®, TwinDerm®, and Microcyn® technologies have produced several innovative products over the past four years, and provide patented technology platforms for ongoing product development. For more about Quinnova technology, link to "Our Technologies" page.
Quinnova is committed to being the premier provider of skin and wound care products in the United States. By optimizing our proprietary technologies and aggressively pursuing business development opportunities which support our Vision, we will continue to strengthen our product pipeline with new, innovative therapeutic treatments for skin disease and wound management. For more about Quinnova Business Development.